Choosing and evaluating randomisation methods in clinical trials: a qualitative study

被引：0
|
作者：
Cydney L. Bruce
Mais Iflaifel
Alan Montgomery
Reuben Ogollah
Kirsty Sprange
Christopher Partlett
机构：
[1] University of Nottingham,Nottingham Clinical Trials Unit, School of Medicine
来源：
Trials | / 25卷
关键词：
Randomisation; RCTs; Qualitative; Focus groups;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Choosing Appropriate Estimands in Clinical Trials
    Leuchs, Ann-Kristin
    Zinserling, Joerg
    Brandt, Andreas
    Wirtz, Dorothee
    Benda, Norbert
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (04) : 584 - 592
  • [32] Choosing endpoints in clinical studies and trials
    Chauhan, B. C.
    EYE, 2007, 21 (Suppl 1) : S34 - S37
  • [33] CHOOSING AND EVALUATING PROPERTY LINE SURVEY METHODS
    ONSRUD, HJ
    SURVEYING AND MAPPING, 1985, 45 (02): : 139 - 144
  • [34] ARRACT a real-time randomisation application for clinical trials
    Mejer, N. K.
    Nielsen, D. L.
    Christiansen, B.
    Sengeloev, L.
    Skovby, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S256 - S256
  • [35] Data management in diabetes clinical trials: a qualitative study
    Aynaz Nourani
    Haleh Ayatollahi
    Masoud Solaymani Dodaran
    Trials, 23
  • [36] Data management in diabetes clinical trials: a qualitative study
    Nourani, Aynaz
    Ayatollahi, Haleh
    Dodaran, Masoud Solaymani
    TRIALS, 2022, 23 (01)
  • [37] Qualitative Methods and Process Evaluation in Clinical Trials Context: Where to Head to?
    Cheng, Karis K. F.
    Metcalfe, Alison
    INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2018, 17 (01):
  • [38] A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials
    Som D. Mukherjee
    Megan E. Coombes
    Mitch Levine
    Jarold Cosby
    Brenda Kowaleski
    Andrew Arnold
    Investigational New Drugs, 2011, 29 : 1013 - 1020
  • [39] Why transition from alternation to randomisation in clinical trials was made
    Chalmers, I
    BRITISH MEDICAL JOURNAL, 1999, 319 (7221): : 1372 - 1372
  • [40] A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials
    Mukherjee, Som D.
    Coombes, Megan E.
    Levine, Mitch
    Cosby, Jarold
    Kowaleski, Brenda
    Arnold, Andrew
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1013 - 1020
12345